Edition:
India

OncoMed Pharmaceuticals Inc (OMED.OQ)

OMED.OQ on NASDAQ Stock Exchange Global Select Market

4.95USD
22 Nov 2017
Change (% chg)

$0.38 (+8.32%)
Prev Close
$4.57
Open
$4.57
Day's High
$4.98
Day's Low
$4.57
Volume
38,425
Avg. Vol
44,980
52-wk High
$10.86
52-wk Low
$2.93

Select another date:

Fri, Nov 3 2017

BRIEF-Oncomed posts Q3 loss per share $0.28

* Oncomed announces third quarter 2017 financial results and operational highlights

BRIEF-OncoMed CEO Paul Hastings to take medical leave of absence

* OncoMed chairman and CEO, Paul Hastings, to take medical leave of absence

BRIEF-OncoMed doses first patient with GITRL-Fc in phase 1a clinical trial

* OncoMed doses first patient with GITRL-Fc in phase 1a clinical trial Source text for Eikon: Further company coverage:

BRIEF-Oncomed Pharmaceuticals Q2 loss per share $0.40

* Q2 revenue $6.2 million versus $6.7 million Source text for Eikon: Further company coverage:

Select another date: